Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bf1e46c56529932d1378010ef0eaa7f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 |
filingDate |
2016-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fcc4d470a3a64e45fa06433755275c3 |
publicationDate |
2017-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017049205-A2 |
titleOfInvention |
Growth hormone formulation |
abstract |
A stable pharmaceutically acceptable aqueous formulation containing human growth hormone linked to an extended recombinant polypeptide (XTEN) and a buffer is disclosed, wherein the formulation is lacking a surfactant. Also disclosed are associated methods for preparing, storing, and using such formulations. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023004036-A3 |
priorityDate |
2015-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |